← All trials

NCT07155174

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 6, 2025
Primary completion
May 31, 2029
Completion date
Sep 30, 2031
First posted
Sep 4, 2025
Last posted
Nov 12, 2025
Enrollment
180
Arms / groups
6 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.